Literature DB >> 32150665

Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time?

Vito Terlizzi1, Gianfranco Mergni1, Claudia Centrone2, Filippo Festini3, Giovanni Taccetti1.   

Abstract

Entities:  

Year:  2020        PMID： 32150665     DOI： 10.1002/ppul.24721

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN： 1099-0496


× No keyword cloud information.
  4 in total

1.  Elevated sweat chloride test: is it always cystic fibrosis?

Authors:  C Cimbalo; A Tosco; V Terlizzi; A Sepe; A Castaldo; L Salvadori; V Raia
Journal:  Ital J Pediatr       Date:  2021-05-14       Impact factor: 2.638

2.  CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?

Authors:  Vito Terlizzi; Rita Padoan; Laura Claut; Carla Colombo; Benedetta Fabrizzi; Marco Lucarelli; Sabina Maria Bruno; Alice Castaldo; Paolo Bonomi; Giovanni Taccetti; Antonella Tosco
Journal:  Diagnostics (Basel)       Date:  2020-12-12

3.  Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience.

Authors:  Chiara Bianchimani; Daniela Dolce; Claudia Centrone; Silvia Campana; Novella Ravenni; Tommaso Orioli; Erica Camera; Gianfranco Mergni; Cristina Fevola; Paolo Bonomi; Giovanni Taccetti; Vito Terlizzi
Journal:  Int J Neonatal Screen       Date:  2022-08-03

4.  G378X-I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency.

Authors:  Vito Terlizzi; Claudia Centrone; Matteo Botti; Giovanni Taccetti
Journal:  Mol Genet Genomic Med       Date:  2022-08-13       Impact factor: 2.473
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.